These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Substituted benzamides as cerebral dopamine antagonists in rodents. Elliott PN; Jenner P; Huizing G; Marsden CD; Miller R Neuropharmacology; 1977 May; 16(5):333-42. PubMed ID: 559256 [No Abstract] [Full Text] [Related]
3. The effect of chronic administration of dopaminergic blocking drugs on the level of enkephalins in the striatum and behavior of rats. Herman ZS; Trzeciak HI; Kowalski J; Obuchowicz E; Huzarska M Pol J Pharmacol Pharm; 1991; 43(5):421-32. PubMed ID: 1688094 [No Abstract] [Full Text] [Related]
5. Effect of some benzamide derivatives on stress-induced behavior and striatum dopamine receptors. Bondarenko NA; Gorantcheva J; Tyutyulkova N; Nikolova M; Valdman AV Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):629-33. PubMed ID: 3236937 [TBL] [Abstract][Full Text] [Related]
6. Differential inhibitory effects of ascorbic acid on the binding of dopamine agonists and antagonists to neostriatal membrane preparations: correlations with behavioral effects. Heikkila RE; Cabbat FS; Manzino L Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):409-21. PubMed ID: 7323442 [TBL] [Abstract][Full Text] [Related]
7. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction. Randrup A Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170 [No Abstract] [Full Text] [Related]
8. A comparison of the effect of substituted benzamides in radioreceptor binding assays with their effects on brain dopaminergic systems in vivo. Lin CW; Wilk S Adv Biochem Psychopharmacol; 1982; 35():51-60. PubMed ID: 6183929 [No Abstract] [Full Text] [Related]
9. Asymmetrical effect of delta-9-tetrahydrocannabinol (THC) on striatal dopamine and behavior. Waters DH; Glick SD Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):57-63. PubMed ID: 4734017 [No Abstract] [Full Text] [Related]
10. The substituted benzamides--a novel class of dopamine antagonists. Jenner P; Marsden CD Life Sci; 1979 Aug; 25(6):479-85. PubMed ID: 40086 [No Abstract] [Full Text] [Related]
12. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity. Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634 [TBL] [Abstract][Full Text] [Related]
13. [Rat's nigrostriatal dopamine system under the influence of insulin in alloxan diabetes]. Majewski K; Braszko J; Wiśniewski K Psychiatr Pol; 1993; 27(3):325-35. PubMed ID: 8356179 [No Abstract] [Full Text] [Related]
14. New benzamide-derived 5-HT3 receptor antagonists which prevent the effects of ethanol on extracellular dopamine, and fail to reduce voluntary alcohol intake in rats. Iusco G; Boido V; Sparatore F; Colombo G; Saba PL; Rossetti Z; Vaccari A Farmaco; 1997 Mar; 52(3):141-6. PubMed ID: 9212448 [TBL] [Abstract][Full Text] [Related]
15. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties]. Arushanian EB Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251 [No Abstract] [Full Text] [Related]
16. Biochemical and behavioral effects of alaptide, a spirocyclic dipeptide derived from Pro-Leu-Gly-NH2. Dlohozková N; Krejcí I; Hlinák Z; Schuh J; Valchár M Act Nerv Super (Praha); 1989 Apr; 31(1):79-80. PubMed ID: 2782014 [No Abstract] [Full Text] [Related]
18. [On the induction of gastric emptying by clebopride and other antidopaminergic drugs]. Llupiá J; Roberts DJ Arch Farmacol Toxicol; 1979 Dec; 5(3):147-9. PubMed ID: 546330 [No Abstract] [Full Text] [Related]
19. A theoretical conformational study of substituted O-anisamides as models of a class of dopamine antagonists. Pannatier A; Anker L; Testa B; Carrupt PA J Pharm Pharmacol; 1981 Mar; 33(3):145-9. PubMed ID: 6116754 [TBL] [Abstract][Full Text] [Related]